Govt nod to 1st RSV drug for all kids under 2 yrs. Here’s what you need to know
New Delhi: The Central Drugs Standard Control Organisation (CDSCO), India’s apex drug controller, has approved Beyfortus, a medicine for use in all infants against Respiratory Syncytial Virus (RSV) — the top cause of hospitalisation for babies under the age of two in the country. The drug received approval in June this year, French multinational pharmaceutical … Read more
